US stocks starting with J
The official accounts of 29 companies listed in the United States whose name starts with J: revenue and net profit for the latest fiscal year, as stated in the annual report (Form 10-K) each one files with the SEC, in US dollars. Each one links to its page, with the document every figure comes from.
| Company | Ticker | Fiscal year | Revenue | Net profit |
|---|---|---|---|---|
| J.B. Hunt | NASDAQ: JBHT | 2025 | $11,999m | $598.3m |
| J.Jill | NYSE: JILL | 2026 | $596.5m | $27.9m |
| J.M. Smucker | NYSE: SJM | 2026 | $9,051m | −$138.7m |
| J&J Snack Foods | NASDAQ: JJSF | 2025 | $1,583m | $65.6m |
| Jabil | NYSE: JBL | 2026 | $35,954m | $1,042m |
| Jack Henry & Associates | NASDAQ: JKHY | 2026 | $2,544m | $502.8m |
| JACK in the Box | NASDAQ: JACK | 2025 | $1,465m | −$80.7m |
| Jacobs Solutions | NYSE: J | 2025 | $12,030m | $289.3m |
| Jade Biosciences | NASDAQ: JBIO | 2025 | — | −$127.4m |
| Jakks Pacific | NASDAQ: JAKK | 2025 | — | $9.9m |
| James Hardie Industries | NYSE: JHX | 2026 | $4,836m | $104.0m |
| James River Group | NASDAQ: JRVR | 2025 | $687.6m | $47.4m |
| Janus International Group | NYSE: JBI | 2025 | $884.2m | $53.8m |
| Janux Therapeutics | NASDAQ: JANX | 2025 | $10.0m | −$113.6m |
| Jazz Pharmaceuticals | NASDAQ: JAZZ | 2025 | $4,268m | −$356.1m |
| JBG Smith Properties | NYSE: JBGS | 2025 | $498.6m | −$139.1m |
| JBT Marel | NYSE: JBTM | 2025 | $3,798m | −$50.5m |
| Jefferies Financial Group | NYSE: JEF | 2025 | $10,824m | $682.0m |
| JELD-WEN | NYSE: JELD | 2025 | $3,211m | −$621.2m |
| JetBlue Airways | NASDAQ: JBLU | 2025 | $9,062m | −$602.0m |
| JFrog | NASDAQ: FROG | 2025 | $531.8m | −$71.8m |
| Joby Aviation | NYSE: JOBY | 2025 | $53.4m | −$929.8m |
| John B. Sanfilippo & Son | NASDAQ: JBSS | 2026 | $1,176m | $61.9m |
| John Marshall Bancorp | NASDAQ: JMSB | 2025 | $62.6m | $21.2m |
| Johnson & Johnson | NYSE: JNJ | 2025 | $94,193m | $26,804m |
| Johnson Controls | NYSE: JCI | 2025 | $23,596m | $3,291m |
| Johnson Outdoors | NASDAQ: JOUT | 2025 | $592.4m | −$34.3m |
| Jones Lang LaSalle | NYSE: JLL | 2025 | $26,116m | $792.1m |
| JPMorgan Chase | NYSE: JPM | 2025 | $182,447m | $57,048m |
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.